
Join to View Full Profile
9000 Rockville PikeBethesda, MD 20892
Phone+1 301-451-6330
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tiarnan Keenan, MD is an ophthalmologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maine.
Education & Training
- Oxford University Medical SchoolClass of 2004
Certifications & Licensure
- ME State Medical License 2018 - 2026
Publications & Presentations
PubMed
- Retinal imaging in an era of open science and privacy protection.Nayoon Gim, Marian Blazes, Clara I Sánchez, Luca Zalunardo, Giulia Corradetti
Experimental Eye Research. 2025-03-14 - Publicly available imaging datasets for age-related macular degeneration: Evaluation according to the Findable, Accessible, Interoperable, Reusable (FAIR) principles.Nayoon Gim, Alina Ferguson, Marian Blazes, Sanjay Soundarajan, Aydan Gasimova
Experimental Eye Research. 2025-03-13 - 1 citationsAlcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: Age-Related Eye Diseases Study 2 Report 34.Cameron Duic, Emily Vance, Elvira Agrón, Tiarnán D L Keenan,
Ophthalmology. Retina. 2025-03-01
Press Mentions
- Antioxidant Combo May Slow Vision Loss in Advanced Macular DegenerationAugust 28th, 2024
Grant Support
- Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular DegenerationNATIONAL EYE INSTITUTEPresent
- Medical Retina FellowshipNATIONAL EYE INSTITUTEPresent
- Medical Retina FellowshipNATIONAL EYE INSTITUTEPresent
- NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)NATIONAL EYE INSTITUTEPresent
- NEI Intramural Biorepository for Retinal Diseases (12-EI-0042)NATIONAL EYE INSTITUTEPresent
- Evaluation of Oral Minocycline in Treating Geographic Atrophy Associated with Age-Related Macular DegenerationNATIONAL EYE INSTITUTEPresent